Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]